Literature DB >> 9519346

Oxidative stress during myocardial ischaemia and heart failure.

R Ferrari1, L Agnoletti, L Comini, G Gaia, T Bachetti, A Cargnoni, C Ceconi, S Curello, O Visioli.   

Abstract

Oxidative stress is a condition in which oxidant metabolites exert toxic effects because of their increased production or an altered cellular mechanism of protection. The heart needs oxygen but it is also susceptible to oxidative stress, which occurs during post-ischaemic reperfusion, for example. Ischaemia causes alterations in the defence mechanisms against oxygen free radicals. At the same time, production of oxygen free radicals increases. In man, there is evidence of oxidative stress during surgical reperfusion of the whole heart, or after thrombolysis, and it is related to transient left ventricular dysfunction or stunning. At present, there are few data on oxidative stress in the failing heart. It is not clear whether the defence mechanisms of the myocyte are altered or whether the production of oxygen free radicals is increased, or both. Recent data have shown a close link between oxidative stress and apoptosis. Importantly, tumour necrosis factor causes a rapid rise in intracellular reactive oxygen intermediates and apoptosis. This series of events is not confined to the myocytes, but also occurs at the level of endothelium, where tumour necrosis factor causes expression of inducible nitric oxide synthase, production of the reactive radical nitric oxide, oxidative stress and apoptosis. The immunological response to heart failure may result in endothelial and myocyte dysfunction through oxidative stress-mediated apoptosis. A better understanding of these mechanisms may lead to novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519346

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  29 in total

Review 1.  Statins and the role of nitric oxide in chronic heart failure.

Authors:  Stephan von Haehling; Stefan D Anker; Eberhard Bassenge
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

2.  Protective effect of carvedilol on abnormality of L-type calcium current induced by oxygen free radical in cardiomyocytes.

Authors:  Nian Liu; Ronghui Yu; Yanfei Ruan; Qiang Zhou; Jun Pu; Yang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 3.  Statin therapy in cardiovascular diseases other than atherosclerosis.

Authors:  Dominique Beaudry; Kenneth E Stone; Suzanne Wetherold; John Hemphill; Dat Do; John McClish; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

4.  Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading.

Authors:  Parco M Siu; Emidio E Pistilli; Stephen E Alway
Journal:  J Appl Physiol (1985)       Date:  2008-09-18

5.  Oleuropein attenuates the progression of heart failure in rats by antioxidant and antiinflammatory effects.

Authors:  Zeinab Janahmadi; Ali Akbar Nekooeian; Ali Reza Moaref; Masoomeh Emamghoreishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-08       Impact factor: 3.000

6.  Localization of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress.

Authors:  L M Swift; N Sarvazyan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-03       Impact factor: 4.733

7.  Vitamin E slows the progression of hypercholesterolemia-induced oxidative stress in heart, liver and kidney.

Authors:  Kailash Prasad; Erick D McNair; A Mabood Qureshi; Gudrun Casper-Bell
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

8.  MicroRNA: A matter of life or death.

Authors:  Zhiguo Wang
Journal:  World J Biol Chem       Date:  2010-04-26

9.  Morin, a flavonoid, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats.

Authors:  Khalid S Al-Numair; Govindasamy Chandramohan; Mohammed A Alsaif; Chinnadurai Veeramani; Ahmed S El Newehy
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

10.  Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injury.

Authors:  Basilia Zingarelli; Paul W Hake; Michael O'Connor; Alvin Denenberg; Sue Kong; Bruce J Aronow
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.